Motion Stimulation Therapy Market Report 2026

The motion stimulation therapy market size has grown strongly in recent years. It will grow from $1.96 billion in 2025 to $2.13 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising prevalence of musculoskeletal disorders, increasing rehabilitation needs for aging populations, growing clinical acceptance of motion-based therapies, expansion of physical therapy infrastructure, availability of advanced therapeutic devices.

The motion stimulation therapy market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for personalized rehabilitation treatments, rising adoption of remote and home-based therapy solutions, expansion of neurological disorder treatment programs, growing integration of ai-driven therapy optimization, increasing healthcare investments in rehabilitation technologies. Major trends in the forecast period include increasing adoption of robotic-assisted motion therapy devices, rising integration of sensor-based motion feedback systems, growing use of personalized rehabilitation protocols, expansion of home-based motion therapy solutions, enhanced focus on neuromuscular recovery outcomes.

The rising incidence of musculoskeletal disorders is expected to drive the growth of the motion stimulation therapy market in the coming years. Musculoskeletal disorders are conditions that affect muscles, bones, joints, tendons, and ligaments, causing pain or limiting movement. The increasing prevalence of these disorders is largely due to the aging global population, as joint degeneration and reduced bone density naturally occur over time. Motion stimulation therapy supports the treatment of musculoskeletal disorders by promoting improved mobility and reducing pain. It delivers targeted stimulation to affected areas, facilitating faster recovery and better patient outcomes. For example, in January 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, the prevalence of long-term musculoskeletal (MSK) conditions among people aged 16 and over who self-reported was 18.4% in 2023, up from 17.6% in 2022. As a result, the growing incidence of musculoskeletal disorders is contributing to the expansion of the motion stimulation therapy market.

Key companies in the motion stimulation therapy market are focusing on developing advanced solutions, such as closed-loop spinal cord stimulators, to improve real-time pain management and patient outcomes. Closed-loop spinal cord stimulators are sophisticated devices that continuously monitor nerve signals and automatically adjust stimulation levels to provide personalized and effective pain relief. For instance, in April 2024, Medtronic plc, an Ireland-based medical technology company, received U.S. Food and Drug Administration (FDA) approval for the Inceptiv closed-loop rechargeable spinal cord stimulator for chronic pain management. This device enhances motion stimulation therapy by dynamically responding to patients’ movements and pain levels. It monitors nerve signals 50 times per second and automatically adjusts stimulation in real time to provide consistent, individualized pain relief throughout daily activities. Additionally, it is the smallest and thinnest spinal cord stimulator available and offers full-body MRI compatibility at both 1.5T and 3T, ensuring patient comfort and uninterrupted access to diagnostic imaging.

In February 2023, Confluent Health LLC, a US-based healthcare company, acquired Motion PT Group for an undisclosed amount. Through this acquisition, Confluent Health aims to expand its national presence and enhance patient care by increasing access to advanced management services and innovative musculoskeletal health programs. Motion PT Group is a US-based company specializing in motion stimulation therapy.

Major companies operating in the motion stimulation therapy market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Ottobock SE & Co. KGaA, Nevro Corporation, Zynex Medical Inc., BTL Industries Inc., Onward Medical Inc., Enraf-Nonius B.V., Hocoma AG, Tyromotion GmbH, Ekso Bionics Holdings Inc., Mettler Electronics Corporation, Bioness Inc., Restorative Therapies Inc., ARPwave Therapy, Innovative Neurotronics Inc., St. Jude Medical Inc., Technomed Electronics Co Ltd., LivaNova PLC, NeuroMetrix Inc., EMS Physio Ltd., Chattanooga Group.

North America was the largest region in the motion simulation therapy market in 2025. The regions covered in the motion stimulation therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the motion stimulation therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the motion stimulation therapy market by increasing costs of imported robotic components, sensors, actuators, electronic control units, and therapeutic hardware used in motion-based rehabilitation systems. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported medical devices, while Asia-Pacific faces pricing pressure on equipment manufacturing and exports. These tariffs are raising procurement costs and slowing device replacement cycles. However, they are also encouraging domestic production of therapy equipment, localized assembly, and increased investment in cost-efficient rehabilitation technologies.

The motion stimulation therapy market research report is one of a series of new reports that provides motion stimulation therapy market statistics, including motion stimulation therapy industry global market size, regional shares, competitors with a motion stimulation therapy market share, detailed motion stimulation therapy market segments, market trends and opportunities, and any further data you may need to thrive in the motion stimulation therapy industry. This motion stimulation therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Motion stimulation therapy is a therapeutic approach that employs controlled movements or mechanical motion to stimulate the body or specific tissues. Its primary goal is to improve circulation, reduce muscle stiffness, and promote healing by encouraging natural motion and providing sensory feedback. This therapy is commonly used in rehabilitation to enhance mobility and alleviate pain.

The main types of motion stimulation therapy include functional neuromuscular motion stimulation therapy, peripheral motion stimulation therapy, deep brain motion stimulation therapy, and therapeutic electrical motion stimulation therapy. Functional neuromuscular motion stimulation therapy uses electrical stimulation to activate muscles and nerves, improving muscle function and motor control. This therapy is applied across various medical areas, including diabetes management, pain management, oncology, cardiovascular diseases, infectious diseases, and others, and is utilized by end-users such as hospitals, specialty clinics, and other healthcare facilities.

The motion stimulation therapy market consists of revenues earned by entities by providing services such as soft tissue motion therapy, limb motion stimulation, subthalamic nucleus stimulation, and pain management stimulation. The market value includes the value of related goods sold by the service provider or included within the service offering. The motion stimulation therapy market also includes sales of spinal cord stimulators, wearable motion therapy devices, vagus nerve stimulators, and implantable pulse generators. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.